Ignite Creation Date:
2024-05-06 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03647488
Status:
COMPLETED
Last Update Posted:
2022-01-24
First Post:
2018-08-20
Brief Title:
Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer
Sponsor:
Organization:
Novartis